RYTM: Rhythm Pharmaceuticals, Inc. Stock

by  •  • Comments Off on RYTM: Rhythm Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4,324.64
Enterprise Value ($M) 4,472.21
Book Value ($M) 163.09
Book Value / Share 0.30
Price / Book 26.52
NCAV ($M) 145.69
NCAV / Share 2.29
Price / NCAV 29.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.65
Return on Equity (ROE) -2.74

Liquidity (mrq)
Quick Ratio 3.13
Current Ratio 3.30

Balance Sheet (mrq) ($M)
Current Assets 369.29
Assets 386.69
Liabilities 223.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 130.13
Operating Income -265.50
Net Income -260.60
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -113.88
Cash from Investing -48.17
Cash from Financing 191.24

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A Perceptive Advisors Llc 6.80 -18.62
05-15 13G/A Baker Bros. Advisors Lp 8.90 -12.41
05-13 13G/A Primecap Management Co/ca/ 9.15 -11.93
04-24 13G/A BlackRock, Inc. 6.90 -31.28
02-10 13G/A Goldman Sachs Group Inc 3.00 -53.25
11-14 13G/A Ra Capital Management, L.p. 9.95 14.15

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-28 10-K ‘ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 198,449 630,945 31.45
2025-06-05 178,161 578,670 30.79
2025-06-04 146,568 402,064 36.45
2025-06-03 190,366 667,390 28.52
2025-06-02 102,298 317,414 32.23

(click for more detail)

Similar Companies
RLAY – Relay Therapeutics, Inc. RNA – Avidity Biosciences, Inc.
RNAC – Cartesian Therapeutics, Inc. SAGE – Sage Therapeutics, Inc.
SCYX – SCYNEXIS, Inc.


Financial data and stock pages provided by
Fintel.io